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Out of 5 cases herein taken into account, 3 cases 
presented with a rearranged ETV6 gene, and only one 
of these cases was identified to carry an ETV6/BAZ2 
hybrid gene. This case was a 3-year-old girl with a pre-
B acute lymphoblastic leukaemia (CD10+ ALL). She 
achieved complete remission (CR), and was remaining 
in CR 18 months after diagnosis (Panagopoulos et al., 
2006).  
The 2 other ETV6+ cases were acute myeloid leukemia 
(AML) cases: a 77-year-old male patient with AML-
M2. Complete remission was achieved; he relapsed and 
died of sepsis (Saitoh et al., 2002); and a 46-yearold 
female patient with treatment related AML-M2, 
developping years after treatment for breast cancer; th  
patient has been in continuous relapse for the last 4 
months after onset of AML (Manola et al., 2008).  
The 2 last cases were: a 4-years-old boy with ALL; the 
patient was alive 27 months after diagnosis (Heerema 
et al., 1985); and a 62-years-old female patient with 
AML-M6 with a 2 months survival (Mazzella et al., 
1998).  
Altogether, this makes 2 pediatric ALL cases, and 3 
adult AML cases, with perhaps different prognoses 
between the two categories. Excluded here is a case of 
refractory anemia with excess blasts with HMGA2 
involvement (Odero et al., 2005), although the 4 above 
mentionned cases where BAZ2A was not studied may 






In the case where ETV6/BAZ2A rearrangement was 
ascertained, the rearrangement between 12p13 and 
12q13 was cryptic (Panagopoulos et al., 2006). The 
other ALL case also had a trisomy 16 and a trisomy 21.  
The t(12;12)(p13;q13) was an additional anomaly to a 
t(11;19)(q23;p13.1) in the treatment related AML-M2 
case.  
The apparently de novo AML-M2 case have had a 
del(7q) prior to the t(12;12).  
The M6-AML case had a del(5q), a del(20q) and a 
complex karyotype. 





ETV6 is a transcriptional repressor belonging to the
ETS family. ETV6 displays a HLH domain (also 
referred to as the pointed (PNT) or sterile alpha motif 
(SAM) domain), responsible for hetero- and 
homodimerization, a central domain involved in the 
recruitment of a repression complex including NCOR2 
and SIN3, and an ETS domain, responsible for 
sequence specific DNA-binding to DNA-responsive 
elements.  
Repression involves the recruitment of co-repressor 
complexes and HDACs or the recruitment of 
L3MBTL-containing polycomb group-complexes that 
facilitate repression by chromatin remodeling. ETV6  
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binds to nuclear receptors RARA and RXRA and 
represses gene activation. ETV6 is as a selective and 
essential regulator of stem cells, important in vitelline 
angiogenesis and in bone marrow hematopoiesis. ETV6 
expands erythroid precursors and stimulates 
hemoglobin synthesis (Knezevich, 2005; Eguchi-





BAZ2A comprises from N-term to C-term a MBD 
(methyl-CpG-binding) domain, 2 AT hooks, a DDT 
(DNA binding homeobox and different transcription 
factors), 2 AT hooks again, a PHD-type zinc finger, 
and a bromo domain. The bromo domain and the PHD-
type zinc finger recognize and bind histone H4. These 2 
domains play a central role in the recruitment of 
chromatin silencing proteins such as DNMT1, 
DNMT3B and HDAC1 (Swiss-Prot). The NoRC 
(nucleolar remodeling complex) comprises BAZ2A and 
SMARCA5. A mechanism for silencing active 
ribosomal RNA (rRNA) genes is the recruitment by 
TTF1 (transcription termination factor-1) of NoRC to 
the promoter of rRNAs in the nucleolus. PARP1, 
component of the machinery that establishes and 
maintains silent rDNA chromatin during cell division, 
binds to BAZ2A (Guetg et al., 2012). BAZ2A is up-
regulated in patients with chronic lymphocytic 
leukemia (Hanlon et al., 2009). 




Transcript consisting of exons 1 and 2 of ETV6 and  
sequence from intron 1 of BAZ2A. This transcript is 
not expected to produce any chimeric protein. 
Fusion protein 
Description 
The transcript may encode a truncated form of ETV6, 
containing the first 54 amino acids (aa) of ETV6, 
followed by 16 aa from the 3' fusion sequence. 
Oncogenesis 
The production of a truncated form of ETV6 is 
reminiscent of ETV6 fusions with MDS2, FCHO2, 
PER1, and STL, according to Panagopoulos et al., 
2006. BAZ2A may also be deregulated. 
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